MEDITE Cancer Diagnostics
Orlando
About MEDITE Cancer Diagnostics
MEDITE® GmbH has grown to be a mid-sized industrial corporation specializing in the development, manufacture and distribution.
Company Facts
- Estimated revenue: $1K – $10K
- Total funding: $6.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2017)
Canonical: https://fsome.com/organization/medite-cancer-diagnostics-8327998 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.